Article detail · 2025
Effect of dexamethasone therapy in Crimean-Congo hemorrhagic fever in Giresun during 2021-2023: an analytical study
JOURNAL OF VECTOR BORNE DISEASES
- Year
- 2025
- ISSN
0972-9062- Type
- article
Data source split
- YÖKSİS YÖKSİS article record
- OpenAlex OpenAlex enrichment (abstract, citations, topics)
Abstract
English (OpenAlex)
BACKGROUND OBJECTIVES: Crimean-Congo hemorrhagic fever (CCHF) is a zoonotic disease and significant health concern particularly in endemic regions. We aimed to evaluate the efficacy in dexamethasone treatment on clinical outcomes in CCHF patients. METHODS: We included adult patients diagnosed with CCHF and those whose platelet count dropped to 70,000/mm3 or lower. The efficacy of dexamethasone on clinical outcomes was evaluated. It was a retrospective analytical study. RESULTS: The study included 55 patients. All patients received standard supportive treatment, and none of them received ribavirin therapy. It was observed that 23 (41.8%) of the patients were treated with dexamethasone. No significant differences were observed between patients treated with dexamethasone and those without dexamethasone treatment, regarding factors such as bleeding incidents during hospitalization, the need for blood product transfusions, thrombocyte recovery status, intensive care unit admission, and in-hospital mortality. In-hospital mortality was observed in two patients among all patients (3.6%). INTERPRETATION CONCLUSION: Our study found that dexamethasone treatment did not lead to a significant improvement in clinical outcomes for CCHF patients.
Topics
- Viral Infections and Vectors
- Mosquito-borne diseases and control
- Vector-borne infectious diseases
Primary topic Viral Infections and Vectors